OCR is focused on comparative medicine studies of dogs with spontaneous cancers and chronic diseases, as natural animal models for assessment of drug candidates under development for Human. OCR provides to Biotech-Pharma-MedTech companies more predictive data of human diseases for a more relevant development in clinic. OCR also acts as a full vet-CRO for pilot and pivotal studies for the Vet market. OCR benefits from an internal histology/IHC platform and a canine and feline tumor biobank